Ann: ZLD and Levin Health to Conduct Chronic Pain Clinical Trial, page-14

@Tahora

Possibly - at least they are putting their targeted drug development program back where it needs it be .....aimed directly at therapeutic medical benefit - Mark Levin is no mug and would not jeopardise reputational standing on fluff imo
this is potentially an investigational study of ZTL-106s' ability to establish itself as a treatment - validated, efficacious treatment with demonstrated safety profile and demonstrated therapeutic benefit for athletes suffering chronic pain.
The importance of this trial at this time is immense imo - Levin likes what it sees and understands the relevance and product differentiation ($$$$$_ ) linked with quality clinical trial data. they are putting their money where their mouth is by funding the trial so Zelira have it on a plate imo - can they execute is the question - as always it remains to be seen - hope so finally
Everything else in the sector that does not pursue this route ( clinically validated trial outcomes) is thumb twiddling in the blackmores category......fluff and fairy dust imo



all the best to them in this trial and the desired outcomes

GLto all holders - especially LTH -
former holder